000 | 01045 a2200277 4500 | ||
---|---|---|---|
005 | 20250515015811.0 | ||
264 | 0 | _c20060307 | |
008 | 200603s 0 0 eng d | ||
022 | _a1533-4406 | ||
024 | 7 |
_a10.1056/NEJMc053396 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMoskowitz, David W | |
245 | 0 | 0 |
_aAcute oxygen-sensing mechanisms. _h[electronic resource] |
260 |
_bThe New England journal of medicine _cMar 2006 |
||
300 |
_a975-7; author reply 975-7 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 |
_aAngiotensin II _xantagonists & inhibitors |
650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLung Diseases _xdrug therapy |
650 | 0 | 4 | _aOxidation-Reduction |
650 | 0 | 4 |
_aOxygen _xphysiology |
650 | 0 | 4 |
_aPeptidyl-Dipeptidase A _xmetabolism |
773 | 0 |
_tThe New England journal of medicine _gvol. 354 _gno. 9 _gp. 975-7; author reply 975-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMc053396 _zAvailable from publisher's website |
999 |
_c16121049 _d16121049 |